Alexandra Thomas
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 29
- Oncology 45
- HER2/EGFR in Cancer Research 11
- Cancer Treatment and Pharmacology 10
- Cancer Diagnosis and Treatment 5
- Co-authors
- Mary C. SchroederPaul A. RomittiElizabeth A. ChrischillesSeema A. KhanLance D. MillerCharles E. GeyerLacey R. McNallyPriya Rastogi
- Journals
- Journal of Clinical Oncology (17 papers)Clinical Breast Cancer (9 papers)Cancer Research (6 papers)Clinical Cancer Research (3 papers)JNCI Cancer Spectrum (3 papers)
- Partner nations
- United StatesIrelandItaly
In The Last Decade
Alexandra Thomas
84 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 559
- Oncology 751
- Pathology and Forensic Medicine 232
- Pulmonary and Respiratory Medicine 365
- Immunology 166
Countries citing papers authored by Alexandra Thomas
This map shows the geographic impact of Alexandra Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Thomas more than expected).
Fields of papers citing papers by Alexandra Thomas
This network shows the impact of papers produced by Alexandra Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Thomas. The network helps show where Alexandra Thomas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexandra Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 10 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 82 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 76 | |
| 11 | 2020 | 0 | |
| 12 | 2020 | 7 | |
| 13 | 2020 | 9 | |
| 14 | 2018 | 209 | |
| 15 | 2018 | 13 | |
| 16 | 2017 | 31 | |
| 17 | 2017 | 13 | |
| 18 | 2014 | 33 | |
| 19 | 2013 | 2 | |
| 20 | 2011 | 0 |
About Alexandra Thomas
Alexandra Thomas is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Health Informatics and Pulmonary and Respiratory Medicine, having authored 94 papers that have together received 1.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (29 papers), Advanced Breast Cancer Therapies (12 papers), Breast Lesions and Carcinomas (11 papers), HER2/EGFR in Cancer Research (11 papers), Cancer Treatment and Pharmacology (10 papers), Nanoplatforms for cancer theranostics (8 papers), BRCA gene mutations in cancer (5 papers) and Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (559 citations), Oncology (751 citations), Pathology and Forensic Medicine (232 citations), Pulmonary and Respiratory Medicine (365 citations) and Immunology (166 citations). Alexandra Thomas has collaborated with scholars based in United States, Ireland and Italy. Frequent co-authors include Mary C. Schroeder, Paul A. Romitti, Elizabeth A. Chrischilles, Seema A. Khan, Lance D. Miller, Charles E. Geyer, Lacey R. McNally, Priya Rastogi, Guangxu Jin and Karen Daily. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Cancer Research, Clinical Cancer Research and JNCI Cancer Spectrum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.